Genmab A/S
GMAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434265
No open-market purchases or sales by Genmab A/S insiders were filed in the last 90 days; 291 institutions reported holding it in 13F filings for Q2 2026, worth $2.81B in total; no superinvestor holds it.
Other share classesGNMSF
Holders of 5% or more of GMAB
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Genmab A/S, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Genmab A/S on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Genmab A/S, newest first.
No Schedule 13D or 13G filings on Genmab A/S are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Genmab A/S shares.
No Form 144 notices for Genmab A/S are on file.